OA11838A - Gardos channel antagonists. - Google Patents
Gardos channel antagonists. Download PDFInfo
- Publication number
- OA11838A OA11838A OA1200100220A OA1200100220A OA11838A OA 11838 A OA11838 A OA 11838A OA 1200100220 A OA1200100220 A OA 1200100220A OA 1200100220 A OA1200100220 A OA 1200100220A OA 11838 A OA11838 A OA 11838A
- Authority
- OA
- OAPI
- Prior art keywords
- substituent
- acetamide
- ring
- compound
- para
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13551199P | 1999-02-23 | 1999-02-23 | |
US09/386,601 US6288122B1 (en) | 1999-02-23 | 1999-08-31 | Gardos channel antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
OA11838A true OA11838A (en) | 2005-08-22 |
Family
ID=26833406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200100220A OA11838A (en) | 1999-02-23 | 2000-02-10 | Gardos channel antagonists. |
Country Status (16)
Country | Link |
---|---|
US (1) | US6288122B1 (ko) |
EP (1) | EP1158971B1 (ko) |
JP (2) | JP4038337B2 (ko) |
KR (1) | KR100705726B1 (ko) |
CN (1) | CN1193748C (ko) |
AP (1) | AP1465A (ko) |
AT (1) | ATE370728T1 (ko) |
AU (1) | AU762039B2 (ko) |
BR (1) | BR0008416A (ko) |
CA (1) | CA2371857C (ko) |
DE (1) | DE60036093T2 (ko) |
ES (1) | ES2291191T3 (ko) |
HK (1) | HK1045262B (ko) |
IL (2) | IL145012A0 (ko) |
OA (1) | OA11838A (ko) |
WO (1) | WO2000050026A1 (ko) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003004010A1 (en) * | 2001-07-06 | 2003-01-16 | Poseidon Pharmaceuticals A/S | Carbonylamino derivatives useful for obtaining immune regulation |
US7208527B2 (en) | 2002-01-04 | 2007-04-24 | Poseidon Pharmaceuticals A/S | Potassium channel modulators |
US20040029771A1 (en) * | 2002-02-28 | 2004-02-12 | Icagen, Inc. | Methods for treating diseases related to intraocular pressure |
US20070027205A1 (en) * | 2003-07-03 | 2007-02-01 | Joachim Demnitz | Diarylmethyl derivatives as potassium channel modulators |
WO2005003143A1 (en) * | 2003-07-03 | 2005-01-13 | Poseidon Pharmaceuticals A/S | Novel potassium channel modulators |
EP1861356A1 (en) * | 2005-02-01 | 2007-12-05 | Icagen, Inc. | Imines as ion channel modulators |
CN101437403A (zh) * | 2005-12-20 | 2009-05-20 | Icagen公司 | 使用三芳基甲烷化合物的治疗方法 |
US20100056637A1 (en) * | 2005-12-20 | 2010-03-04 | Icagen, Inc. | Treatment methods using triaryl methane compounds |
PT2192896E (pt) | 2007-08-24 | 2011-04-04 | Neurosearch As | Derivados de carbonilamino úteis para o tratamento de doença inflamatória intestinal |
US20090076157A1 (en) * | 2007-09-15 | 2009-03-19 | Protia, Llc | Deuterium-enriched senicapoc |
AU2009233807B2 (en) | 2008-04-09 | 2014-11-27 | Cerus Corporation | Improved quenching methods for red blood cell pathogen inactivation |
EP2358750B1 (en) | 2008-11-10 | 2017-01-11 | Boehringer Ingelheim International GmbH | Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels |
US10179115B2 (en) | 2015-02-20 | 2019-01-15 | The Children's Medical Center Corporation | Methods for treating malaria using potassium channel inhibitors |
EP3106155A1 (en) * | 2015-06-15 | 2016-12-21 | Universite d'Aix Marseille | Treatment and diagnosis of hereditary xerocytosis |
US11439607B2 (en) * | 2016-10-25 | 2022-09-13 | Paracelsus Neuroscience I, LLC | Use of senicapoc for treatment of neuropathic pain |
WO2018162426A1 (en) | 2017-03-06 | 2018-09-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Treatment and diagnosis of hereditary xerocytosis |
CN112020353A (zh) * | 2019-03-29 | 2020-12-01 | 深圳仁泰医药科技有限公司 | 2,2-双(4-氟苯基)-2-苯乙酰胺的晶型a及其制备方法和应用 |
US20230045322A1 (en) * | 2019-07-29 | 2023-02-09 | Paracelsus Neuroscience II, LLC | Use of senicapoc for treatment of stroke |
US20230248672A1 (en) * | 2020-07-14 | 2023-08-10 | Adimabio Llc | Compositions comprising gardos channel antagonists and their uses |
US20240024335A1 (en) | 2020-12-11 | 2024-01-25 | Sanquin IP B.V. | Treatment and prevention of anaemia of inflammation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273992A (en) | 1992-11-02 | 1993-12-28 | Beth Israel Hospital Assoc. Inc. | Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ |
DE69734983T2 (de) | 1996-03-20 | 2006-09-07 | President And Fellows Of Harvard College, Cambridge | Triarylmethanverbindungen zur behandlung von krebs, aktinischer keratose und kaposisarkom |
-
1999
- 1999-08-31 US US09/386,601 patent/US6288122B1/en not_active Expired - Lifetime
-
2000
- 2000-02-10 ES ES00907283T patent/ES2291191T3/es not_active Expired - Lifetime
- 2000-02-10 AU AU28807/00A patent/AU762039B2/en not_active Ceased
- 2000-02-10 OA OA1200100220A patent/OA11838A/en unknown
- 2000-02-10 BR BR0008416-6A patent/BR0008416A/pt not_active IP Right Cessation
- 2000-02-10 IL IL14501200A patent/IL145012A0/xx active IP Right Grant
- 2000-02-10 JP JP2000600638A patent/JP4038337B2/ja not_active Expired - Fee Related
- 2000-02-10 CN CNB008054525A patent/CN1193748C/zh not_active Expired - Fee Related
- 2000-02-10 AT AT00907283T patent/ATE370728T1/de active
- 2000-02-10 EP EP00907283A patent/EP1158971B1/en not_active Expired - Lifetime
- 2000-02-10 CA CA002371857A patent/CA2371857C/en not_active Expired - Fee Related
- 2000-02-10 DE DE60036093T patent/DE60036093T2/de not_active Expired - Lifetime
- 2000-02-10 AP APAP/P/2001/002268A patent/AP1465A/en active
- 2000-02-10 WO PCT/US2000/003663 patent/WO2000050026A1/en active IP Right Grant
- 2000-02-10 KR KR1020017010707A patent/KR100705726B1/ko not_active IP Right Cessation
-
2001
- 2001-08-21 IL IL145012A patent/IL145012A/en not_active IP Right Cessation
-
2002
- 2002-09-16 HK HK02106773.8A patent/HK1045262B/zh not_active IP Right Cessation
-
2007
- 2007-05-02 JP JP2007121967A patent/JP2007262075A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HK1045262A1 (en) | 2002-11-22 |
CN1344158A (zh) | 2002-04-10 |
AP1465A (en) | 2005-09-22 |
IL145012A0 (en) | 2002-06-30 |
BR0008416A (pt) | 2002-01-29 |
AP2001002268A0 (en) | 2001-09-30 |
HK1045262B (zh) | 2005-07-29 |
WO2000050026A1 (en) | 2000-08-31 |
AU762039B2 (en) | 2003-06-19 |
KR20020002393A (ko) | 2002-01-09 |
DE60036093D1 (de) | 2007-10-04 |
JP4038337B2 (ja) | 2008-01-23 |
JP2002537331A (ja) | 2002-11-05 |
CN1193748C (zh) | 2005-03-23 |
KR100705726B1 (ko) | 2007-04-11 |
CA2371857A1 (en) | 2000-08-31 |
CA2371857C (en) | 2008-07-29 |
US6288122B1 (en) | 2001-09-11 |
IL145012A (en) | 2006-12-10 |
DE60036093T2 (de) | 2008-05-15 |
ES2291191T3 (es) | 2008-03-01 |
EP1158971A4 (en) | 2003-04-16 |
EP1158971A1 (en) | 2001-12-05 |
EP1158971B1 (en) | 2007-08-22 |
JP2007262075A (ja) | 2007-10-11 |
ATE370728T1 (de) | 2007-09-15 |
AU2880700A (en) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA11838A (en) | Gardos channel antagonists. | |
US4400394A (en) | Benzylidene derivatives | |
BR9908084B1 (pt) | composto 2-fenil-1-(3,4-diidróxi-5-nitrofenil)-1-etanona, composição farmacêutica, e, uso de um composto. | |
US20100056637A1 (en) | Treatment methods using triaryl methane compounds | |
PL154186B1 (en) | Method for manufacturing arylic derivatives of the hydroxamic acid | |
JPH04270261A (ja) | イソプレノイドホスホリパーゼ▲a2▼阻害剤およびそれを包含する製剤 | |
JPS61218570A (ja) | 新規複素環アミド化合物、およびそれらを含有する医薬組成物 | |
US4797391A (en) | ((5,6-dichloro-3-oxo-9,9a-disubstituted-2,3,9,9a-tetrahydrofluoren-7-yl)oxy)alkanoic acids and alkanimidamides | |
CS267551B1 (en) | Pharmaceutical agents for asthma treatment and method of effective substance production | |
US4835313A (en) | (5,6-dichloro-3-oxo-9α-propyl-2,3,9,9α-tetrahydrofluoren-7-yl) alkanimidamides | |
Abood et al. | Carbamate ester latentiation of physiologically active amines | |
AU2006320567A1 (en) | Inhibitors of kynurenine aminotransferase and uses therefor | |
KR950013577B1 (ko) | 카르복스아미드 유도체 | |
US4562206A (en) | Orally effective inotropic compounds | |
US3856951A (en) | Substituted benzoic acid hypoliphemic agents | |
ZA200106847B (en) | Gardos channel antagonists. | |
US4418074A (en) | 2,6 Di(t-butyl)-4-(2'-pyrrol)-phenol and anti-inflammatory use thereof | |
US20060100289A1 (en) | Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain | |
JPS6330283B2 (ko) | ||
US3457354A (en) | Treatment of hypertension with 2-hydroxy (or amino) - 4,5 - dihydroxyphenethylamine derivatives | |
JPH08325154A (ja) | 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼa2阻害剤 | |
US4146728A (en) | Esters of 2-[4-(4-chlorobenzoyl)-phenoxy-2-methyl-propionic acid with bis-(hydroxyalkylthio)-alkanes | |
US3740395A (en) | Ethyl 10 - (beta-morpholylpropionyl)-phenthiazine-2-carbamate hydrochloride | |
US3673197A (en) | Exo-dibicycloalkane carboxamides | |
JPH0374673B2 (ko) |